News

Construction is underway for a new cell therapy manufacturing facility in Devens, MA, a part of Bristol Myers Squibb’s significant investment to support clinical and commercial manufacturing of transformative cell therapies for patients with aggressive hematological cancers. The Devens site...

Sterile and contained pharmaceutical product transfer specialist, ChargePoint Technology (“ChargePoint” or the “Company”), has today announced that it has been acquired by Arcline Investment Management (“Arcline”). The deal will see ChargePoint Technology, headquartered in Liverpool, UK, become part of...

Phesi Inc., a leading provider of AI-based clinical development analytics products and solutions, is showcasing its data-driven clinical development approach at SCOPE Virtual Summit for Clinical Operations Executives 2021, in a case study session with international pharmaceutical company, Alfasigma....

Albany Molecular Research, Inc. (AMRI), a leading global provider of advanced contract research, development and manufacturing solutions, announced that the company has been chosen to support the development and manufacture of lipid excipients for the Pfizer-BioNTech COVID-19 vaccine. For the...

Malvern Panalytical, a leading analytical instruments and services supplier, launches a new version of its Aeris compact X-ray diffractometer (XRD). Aeris is a small-footprint system with a big heart, and even bigger ambitions. This new version contains capabilities previously...

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announces it is making new capital investments to increase capacity at its owned and partnered manufacturing facilities, which it expects will increase global 2022 capacity to approximately...

AiCure and OncoBay Clinical announced a partnership to provide oncology sponsors with scalable, AI-powered insights to improve patient care and optimize drug development. A subsidiary of the Moffitt Cancer Center, OncoBay will make AiCure's proprietary AI platform available for...